717-01-1Relevant articles and documents
PIPERAZINE DERIVATIVES AS MAGL INHIBITORS
-
Page/Page column 207, (2019/05/02)
The invention provides new heterocyclic compounds having general Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, X, Y1 and Y2 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
BENZOIC ACID COMPOUNDS FOR REDUCING URIC ACID
-
Paragraph 0270; 0271, (2017/04/11)
Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including g
SPIRO AZETIDINE ISOXAZOLE DERIVATIVES AND THEIR USE AS SSTR5 ANTAGONISTS
-
Paragraph 0671, (2014/09/29)
Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.
Synthesis and chiral discrimination of cyclic aromatic amides and the determination of their absolute configuration by TD-DFT calculations
Katagiri, Kosuke,Ikeda, Takashi,Muranaka, Atsuya,Uchiyama, Masanobu,Tominaga, Masahide,Azumaya, Isao
scheme or table, p. 2646 - 2650 (2010/03/25)
Novel chiral cyclic molecules composed of aromatic triamides were constructed in modest yield from 4-N-(4′-methoxybenzyl)amino-3-decyloxybenzoic acid using dichlorotriphenylphosphorane, because of the preorganized component of the tertiary benzanilide moi
Toward a novel class of antithrombotic compounds with dual function. Discovery of 1,4-benzoxazin-3(4H)-one derivatives possessing thrombin inhibitory and fibrinogen receptor antagonistic activities
Anderluh, Petra ?tefani?,Anderluh, Marko,Ila?, Janez,Mravljak, Janez,Dolenc, Marija Sollner,Stegnar, Mojca,Kikelj, Danijel
, p. 3110 - 3113 (2007/10/03)
A novel class of potential antithrombotic compounds with moderate thrombin inhibitory and fibrinogen receptor antagonistic activity is described. Combination of anticoagulant and antiaggregatory activity in the same molecular entity is presented as a new
ANTITHROMBOTIC COMPOUNDS WITH DUAL FUNCTION
-
Page/Page column 43-45, (2010/02/11)
The present invention comprises compounds of the general formula (I) : and pharmaceutically acceptable salts thereof, wherein the substituents have in the description specified meaning. The compounds are used as antithrombotic agents possessing inhibitory